Research progress of in-situ gelling ophthalmic drug delivery system

Addo, 2016, Anatomy of the eye and common diseases affecting the eye, 11 Joseph, 2017, Drug delivery to the eye: what benefits do nanocarriers offer, Nanomedicine (Lond), 12, 683, 10.2217/nnm-2016-0379 Zhu, 2017, A novel thermo-sensitive hydrogel-based on poly(N-isopropylacrylamide)/ hyaluronic acid of ketoconazole for ophthalmic delivery, Artif Cells Nanomed Biotechnol Bisht, 2018, Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases, WIREs Nanomed Nanobiotechnol, 10.1002/wnan.1473 Makwana, 2016, Development and characterization of in-situ gel for ophthalmic formulation containing ciprofloxacin hydrochloride, Results Pharma Sci, 6, 1, 10.1016/j.rinphs.2015.06.001 Kaur, 2002, Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery, Drug Dev Ind Pharm, 28, 353, 10.1081/DDC-120002997 Bamiro, 2016, Background of Ocular Drug Delivery, 1 Kotreka, 2017, Development of topical ophthalmic in situ gel-forming estradiol delivery system intended for the prevention of age-related cataracts, PLoS One, 12, 10.1371/journal.pone.0172306 Ye, 2013, Prodrugs incorporated into nanotechnology-based drug delivery systems for possible improvement in bioavailability of ocular drugs delivery, Asian J Pharmaceut Sci, 8, 207, 10.1016/j.ajps.2013.09.002 Liu, 2010, In situ gelling gelrite/alginate formulations as vehicles for ophthalmic drug delivery, AAPS PharmSciTech, 11, 610, 10.1208/s12249-010-9413-0 Tan, 2017, Bioadhesive chitosan-loaded liposomes: a more efficient and higher permeable ocular delivery platform for timolol maleate, Int J Biol Macromol, 94, 355, 10.1016/j.ijbiomac.2016.10.035 Addo, 2015, Formulation and characterization of atropine sulfate in albumin-chitosan microparticles for in vivo ocular drug delivery, J Pharm Sci, 104, 1677, 10.1002/jps.24380 Biswas, 2017, Niosomes in ocular drug delivery, Eur J Pharmaceut Med Res, 4, 813 Prausnitz, 2007, Ocular drug delivery using microneedles, 3191 Duan, 2015, Novel in situ gel systems based on P123/TPGS mixed micelles and gellan gum for ophthalmic delivery of curcumin, Colloids Surf B Biointerfaces, 128, 322, 10.1016/j.colsurfb.2015.02.007 Malavade, 2016, Overview of the ophthalmic system, 9 Almeida, 2014, In situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulations, Drug Discov Today, 19, 400, 10.1016/j.drudis.2013.10.001 Weng, 2017, Nanotechnology-based strategies for treatment of ocular disease, Acta Pharm Sin B, 7, 281, 10.1016/j.apsb.2016.09.001 Huang, 2017, Overcoming ocular drug delivery barriers through the use of physical forces, Adv Drug Deliv Rev Achouri, 2013, Recent advances in ocular drug delivery, Drug Dev Ind Pharm, 39, 1599, 10.3109/03639045.2012.736515 Khan, 2015, Development and evaluation of a novel in situ gel of sparfloxacin for sustained ocular drug delivery: in vitro and ex vivo characterization, Pharm Dev Technol, 20, 662, 10.3109/10837450.2014.910807 Li, 2013, Comparison of systemic absorption between ofloxacin ophthalmic in situ gels and ofloxacin conventional ophthalmic solutions administration to rabbit eyes by HPLC-MS/MS, Int J Pharm, 450, 104, 10.1016/j.ijpharm.2013.04.018 Devasani, 2016, An overview of in situ gelling systems, Pharmaceut Biolog Evaluat, 3, 60 Cao, 2007, Poly(N-isopropylacrylamide)-chitosan as thermosensitive in situ gel-forming system for ocular drug delivery, J Control Release, 120, 186, 10.1016/j.jconrel.2007.05.009 Sheshala, 2015, In situ gelling ophthalmic drug delivery system: an overview and its applications, Recent Pat Drug Deliv Formul, 9, 237, 10.2174/1872211309666150724101227 Laddha, 2017, An insight to ocular in situ gelling systems, Int J Adv Pharmaceut, 06, 31 Wei, 2002, Thermosetting gels with modulated gelation temperature for ophthalmic use: the rheological and gamma scintigraphic studies, J Control Release, 83, 65, 10.1016/S0168-3659(02)00175-X Patel, 2016, Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability, Drug Deliv, 23, 3712, 10.1080/10717544.2016.1223225 Klouda, 2015, Thermoresponsive hydrogels in biomedical applications: a seven-year update, Eur J Pharm Biopharm, 97, 338, 10.1016/j.ejpb.2015.05.017 Almeida, 2012, Temperature and pH stimuli-responsive polymers and their applications in controlled and selfregulated drug delivery, J App Pharm Sci, 2, 1 Almeida, 2013, Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview, Expert Opin Drug Deliv, 10, 1223, 10.1517/17425247.2013.796360 Escobar-Chavez, 2006, Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations, J Pharm Pharm Sci, 9, 339 Miyazaki, 2001, In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride, Int J Pharm, 229, 29, 10.1016/S0378-5173(01)00825-0 Zambito, 2011, Polysaccharides as excipients for ocular topical formulations, 253 Rajoria, 2012, In-situ gelling system: a novel approach for ocular drug delivery, Am J PharmTech Res, 2, 24 Pal, 2013, Biopolymers in controlled-release delivery systems, 347 Mohammed, 2017, Thermosensitive hydrogel as an in situ gelling antimicrobial ocular dressing, Mater Sci Eng C Mater Biol Appl, 78, 203, 10.1016/j.msec.2017.04.065 Liu, 2016, In situ forming hydrogels based on chitosan for drug delivery and tissue regeneration, Asian J Pharmaceut Sci, 11, 673, 10.1016/j.ajps.2016.07.001 Chen, 2012, Chitosan-based thermosensitive hydrogel as a promising ocular drug delivery system: preparation, characterization, and in vivo evaluation, J Biomater Appl, 27, 391, 10.1177/0885328211406563 Shastri, 2017, Thiolated chitosan: a boon to ocular delivery of therapeutics, MOJ Bioequiv Availab, 3, 1 Li, 2014, Design and evaluation of a Brinzolamide drug-resin in situ thermosensitive gelling system for sustained ophthalmic drug delivery, Chem Pharm Bull (Tokyo), 62, 1000, 10.1248/cpb.c14-00451 Al-Khateb, 2016, In situ gelling systems based on Pluronic F127/Pluronic F68 formulations for ocular drug delivery, Int J Pharm, 502, 70, 10.1016/j.ijpharm.2016.02.027 Osswald, 2017, In vivo efficacy of an injectable microsphere-hydrogel ocular drug delivery system, Curr Eye Res, 42, 1293, 10.1080/02713683.2017.1302590 Vodithala, 2010, Development and evaluation of thermoreversible ocular gels of ketorolac tromethamine, Int J Biopharm, 1, 39 Morsi, 2016, Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery, Int J Pharm, 506, 57, 10.1016/j.ijpharm.2016.04.021 Bhowmik, 2011, Effect of salts on gelation and drug release profiles of methylcellulose-based ophthalmic thermo-reversible in situ gels, Pharm Dev Technol, 16, 385, 10.3109/10837451003774369 Bhowmick, 2015, Effect of carrageenan and potassium chloride on in-situ gelling ophthalmic drug delivery system based on methylcellulose, Rsc Adv, 5, 60386, 10.1039/C5RA06858D Gratieri, 2010, A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery, Eur J Pharm Biopharm, 75, 186, 10.1016/j.ejpb.2010.02.011 Hsiue, 2002, Preparation of controlled release ophthalmic drops, for glaucoma therapy using thermosensitive poly-N-isopropylacrylamide, Biomaterials, 23, 457, 10.1016/S0142-9612(01)00127-2 Iohara, 2017, Hydrophobically modified polymer/α-cyclodextrin thermoresponsive hydrogels for use in ocular drug delivery, Mol Pharm, 14, 2740, 10.1021/acs.molpharmaceut.7b00291 Sawant, 2016, Formulation and evaluation of sparfloxacin emulsomes-loaded thermosensitive in situ gel for ophthalmic delivery, J Sol-Gel Sci Technol, 77, 654, 10.1007/s10971-015-3897-8 Wang, 2014, Thermoresponsive ophthalmic poloxamer/tween/carbopol in situ gels of a poorly water-soluble drug fluconazole: preparation and in vitro-in vivo evaluation, Drug Dev Ind Pharm, 40, 1402, 10.3109/03639045.2013.828221 Gadad, 2016, Thermosensitive in situ gel for ocular delivery of lomefloxacin, Ind J Pharmaceut Educ Res, 50, S96 Qian, 2010, Preparation and evaluation of in situ gelling ophthalmic drug delivery system for methazolamide, Drug Dev Ind Pharm, 36, 1340, 10.3109/03639041003801893 Asasutjarit, 2011, Optimization and evaluation of thermoresponsive diclofenac sodium ophthalmic in situ gels, Int J Pharm, 411, 128, 10.1016/j.ijpharm.2011.03.054 Ammar, 2010, Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery, Drug Dev Ind Pharm, 36, 1330, 10.3109/03639041003801885 Lin, 2000, Carbopol/pluronic phase change solutions for ophthalmic drug delivery, J Control Release, 69, 379, 10.1016/S0168-3659(00)00329-1 Wu, 2011, Design and evaluation of baicalin-containing in situ pH-triggered gelling system for sustained ophthalmic drug delivery, Int J Pharm, 410, 31, 10.1016/j.ijpharm.2011.03.007 Pang, 2018, Increasing efficacy and reducing systemic absorption of brimonidine tartrate ophthalmic gels in rabbits, Pharm Dev Technol, 23, 231, 10.1080/10837450.2017.1328693 Upadhayay, 2016, Norfloxacin loaded pH triggered nanoparticulate in-situ gel for extraocular bacterial infections: optimization, ocular irritancy and corneal toxicity, Iran J Pharm Res, 15, 3 Gupta, 2010, Carbopol/chitosan based pH triggered in situ gelling system for ocular delivery of timolol maleate, Sci Pharm, 78, 959, 10.3797/scipharm.1001-06 Kanoujia, 2012, Formulation and characterization of a novel pH-triggered in-situ gelling ocular system containing Gatifloxacin, Int Current Pharmaceut J, 1, 43, 10.3329/icpj.v1i3.9661 Sheikh, 2017, Development and characterization of novel in situ gel of moxifloxacin hydrochloride, Asian J. Pharm., 11, S616 Rupenthal, 2011, Comparison of ion-activated in situ gelling systems for ocular drug delivery. part 2: precorneal retention and in vivo pharmacodynamic study, Int J Pharm, 411, 78, 10.1016/j.ijpharm.2011.03.043 Agrawal, 2012, In situ gel systems as 'smart'carriers for sustained ocular drug delivery, Expert Opin Drug Deliv, 9, 383, 10.1517/17425247.2012.665367 Fernandez-Ferreiro, 2014, Cyclodextrin-polysaccharide-based, in situ-gelled system for ocular antifungal delivery, Beilstein J Org Chem, 10, 2903, 10.3762/bjoc.10.308 Reed, 2016, Enhancement of ocular in situ gelling properties of low acyl gellan gum by use of ion exchange, J Ocul Pharmacol Ther, 32, 574, 10.1089/jop.2016.0084 Champalal, 2012, Current status of ophthalmic in-situ forming hydrogel, Int J Pharma Bio Sci, 3, P372 Mishra, 2008, Design and characterization of bioadhesive in-situ gelling ocular inserts of Gatifloxacin sesquihydrate, DARU: J Pharmaceut Sci, 16, 1 Nirmal, 2010, In-situ gel: new trends in controlled and sustained drug delivery system, Int J PharmTech Res, 2, 1398 Vijaya, 2011, Ion-activated in situ gelling ophthalmic delivery systems of Azithromycin, Indian J of Pharm Sci, 73, 615, 10.4103/0250-474X.100234 Zhu, 2015, A novel in situ gel base of deacetylase gellan gum for sustained ophthalmic drug delivery of ketotifen: in vitro and in vivo evaluation, Drug Des Devel Ther, 9, 3943 Kesarla, 2016, Preparation and evaluation of nanoparticles loaded ophthalmic in situ gel, Drug Deliv, 23, 2363, 10.3109/10717544.2014.987333 Tayel, 2013, Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits, Int J Pharm, 443, 293, 10.1016/j.ijpharm.2012.12.049 Liu, 2006, Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin, Int J Pharm, 315, 12, 10.1016/j.ijpharm.2006.01.029 Liu, 2007, Study on the ocular pharmacokinetics of ion-activated in situ gelling ophthalmic delivery system for gatifloxacin by microdialysis, Drug Dev Ind Pharm, 33, 1327, 10.1080/03639040701397241 Morsi, 2017, Nanoemulsion-based electrolyte triggered in situ gel for ocular delivery of acetazolamide, Eur J Pharm Sci, 104, 302, 10.1016/j.ejps.2017.04.013 Rupenthal, 2011, Ion-activated in situ gelling systems for antisense oligodeoxynucleotide delivery to the ocular surface, Mol Pharm, 8, 2282, 10.1021/mp200140e Yu, 2017, A novel pH-induced thermosensitive hydrogel composed of carboxymethyl chitosan and poloxamer cross-linked by glutaraldehyde for ophthalmic drug delivery, Carbohydr Polym, 155, 208, 10.1016/j.carbpol.2016.08.073 Davaran, 2015, Preparation and in vivo evaluation of in situ gel system as dual thermo-/pH-responsive nanocarriers for sustained ocular drug delivery, J Microencapsul, 32, 511 Gupta, 2015, Physiologically active hydrogel (in situ gel) of sparfloxacin and its evaluation for ocular retention using gamma scintigraphy, J Pharm Bioallied Sci, 7, 195, 10.4103/0975-7406.160015 Gupta, 2010, Ion- and pH-activated novel in-situ gel system for sustained ocular drug delivery, J Drug Target, 18, 499, 10.3109/10611860903508788 Gupta, 2015, An alternative in situ gel-formulation of levofloxacin eye drops for prolong ocular retention, J Pharm Bioallied Sci, 7, 9, 10.4103/0975-7406.149810 Basaran, 2012, Thermosensitive and pH induced in situ ophthalmic gelling system for ciprofloxacin hydrochloride: hydroxypropyl-beta-cyclodextrin complex, Acta Pol Pharm, 69, 1137 Pardeshi, 2012, Solid lipid based nanocarriers: an overview, Acta Pharm, 62, 433, 10.2478/v10007-012-0040-z Gupta, 2010, Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery, Nanomedicine, 6, 324, 10.1016/j.nano.2009.10.004 Pitorre, 2017, Recent advances in nanocarrier-loaded gels: which drug delivery technologies against which diseases?, J Control Release, 266, 140, 10.1016/j.jconrel.2017.09.031 Liu, 2016, Thermosensitive in situ nanogel as ophthalmic delivery system of curcumin: development, characterization, in vitro permeation and in vivo pharmacokinetic studies, Pharm Dev Technol, 21, 576, 10.3109/10837450.2015.1026607 Pandurangan, 2016, Formulation and evaluation of voriconazole ophthalmic solid lipid nanoparticles in situ gel, Int J Pharm Investig, 6, 56, 10.4103/2230-973X.176488 Paradkar, 2017, Formulation development and evaluation of Natamycin niosomal in-situ gel for ophthalmic drug delivery, Journal of Drug Delivery Science & Technology, 39, 113, 10.1016/j.jddst.2017.03.005 Shukr, 2016, Novel in situ gelling ocular inserts for voriconazole-loaded niosomes: design, in vitro characterisation and in vivo evaluation of the ocular irritation and drug pharmacokinetics, J Microencapsul, 33, 71, 10.3109/02652048.2015.1128489 Sayed, 2015, Improved corneal bioavailability of ofloxacin: biodegradable microsphere-loaded ion-activated in situ gel delivery system, Drug Des Devel Ther, 9, 1427 Gupta, 2013, Nanoparticles laden in situ gel of levofloxacin for enhanced ocular retention, Drug Deliv, 20, 306, 10.3109/10717544.2013.838712 Gupta, 2013, Nanoparticles laden in situ gel for sustained ocular drug delivery, J Pharm Bioallied Sci, 5, 162, 10.4103/0975-7406.111824 Ahmed, 2017, A potential in situ gel formulation loaded with novel fabricated poly(lactide-co-glycolide) nanoparticles for enhancing and sustaining the ophthalmic delivery of ketoconazole, Int J Nanomedicine, 12, 1863, 10.2147/IJN.S131850 Yu, 2015, Liposome incorporated ion sensitive in situ gels for opthalmic delivery of timolol maleate, Int J Pharm, 480, 128, 10.1016/j.ijpharm.2015.01.032 Gan, 2009, Novel microemulsion in situ electrolyte-triggered gelling system for ophthalmic delivery of lipophilic cyclosporine A: In vitro and in vivo results, In J Pharm, 365, 143 Singh, 2014, Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study, Drug Dev Ind Pharm, 40, 1223, 10.3109/03639045.2013.814061 Ako-Adounvo, 2014, Recent patents on ophthalmic nanoformulations and therapeutic implications, Recent Pat Drug Deliv Formul, 8, 193, 10.2174/1872211308666140926112000 Kant, 2011, In situ gelling system-An overview, Pharmacologyonline, 2, 28 Jain, 2016, Newer trends in in situ gelling systems for controlled ocular drug delivery, J Anal Pharm Res, 2, 00022, 10.15406/japlr.2016.02.00022 Adeyeye MC, Davis VL, Kotreka UK. In-situ gel ophthalmic drug delivery system of estradiol or other estrogen for prevention of cataracts. US 2011/0082128 A1. 2011. Xia E, Smerbeck RV. Reversible gelling system for ocular drug delivery. US 2002/0114778 A1. 2002. Banerjee R, Carvalho E. Nanoparticulate in-situ gels of TPGS, gellan and PVA as vitreous humor substitutes. US 8,343,471 B2. 2013. Chandavarkar NM, Jindal KC, Malayandi R. In-situ gel forming solution for ocular drug delivery. WO 2011018800 A3. 2011. Xia E, Smerbeck RV. Reversible gelling system for ocular drug delivery. US 6,703,039 B2. 2004. Lin HR, Sung KC. Ophthalmic drug delivery formulations and method for preparing the same. US 6,511,660 B1. 2003.